NCINO INC (NCNO)

US63947X1019 - Common Stock

30.02  +0.86 (+2.95%)

After market: 30.5 +0.48 (+1.6%)

Fundamental Rating

4

NCNO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. The financial health of NCNO is average, but there are quite some concerns on its profitability. NCNO is valued quite expensively, but it does show have an excellent growth rating.



3

1. Profitability

1.1 Basic Checks

NCNO had positive earnings in the past year.
NCNO had a positive operating cash flow in the past year.
In the past 5 years NCNO always reported negative net income.
In multiple years NCNO reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of NCNO (-3.16%) is better than 61.68% of its industry peers.
NCNO has a Return On Equity of -4.03%. This is in the better half of the industry: NCNO outperforms 66.79% of its industry peers.
Industry RankSector Rank
ROA -3.16%
ROE -4.03%
ROIC N/A
ROA(3y)-4.9%
ROA(5y)-6.58%
ROE(3y)-6.23%
ROE(5y)-8.94%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of NCNO (59.86%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NCNO has grown nicely.
The Profit Margin and Operating Margin are not available for NCNO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.72%
GM growth 5Y3.96%

5

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCNO has been increased compared to 1 year ago.
The number of shares outstanding for NCNO has been increased compared to 5 years ago.
NCNO has a better debt/assets ratio than last year.

2.2 Solvency

NCNO has an Altman-Z score of 6.80. This indicates that NCNO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.80, NCNO is in the better half of the industry, outperforming 78.83% of the companies in the same industry.
The Debt to FCF ratio of NCNO is 1.01, which is an excellent value as it means it would take NCNO, only 1.01 years of fcf income to pay off all of its debts.
NCNO's Debt to FCF ratio of 1.01 is fine compared to the rest of the industry. NCNO outperforms 76.64% of its industry peers.
NCNO has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, NCNO perfoms like the industry average, outperforming 59.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.01
Altman-Z 6.8
ROIC/WACCN/A
WACC9.92%

2.3 Liquidity

NCNO has a Current Ratio of 1.17. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
NCNO has a worse Current ratio (1.17) than 70.07% of its industry peers.
A Quick Ratio of 1.17 indicates that NCNO should not have too much problems paying its short term obligations.
NCNO's Quick ratio of 1.17 is on the low side compared to the rest of the industry. NCNO is outperformed by 67.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

7

3. Growth

3.1 Past

NCNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 355.00%, which is quite impressive.
The Revenue has grown by 16.71% in the past year. This is quite good.
Measured over the past years, NCNO shows a very strong growth in Revenue. The Revenue has been growing by 39.10% on average per year.
EPS 1Y (TTM)355%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q333.33%
Revenue 1Y (TTM)16.71%
Revenue growth 3Y32.62%
Revenue growth 5Y39.1%
Revenue growth Q2Q13.27%

3.2 Future

Based on estimates for the next years, NCNO will show a very strong growth in Earnings Per Share. The EPS will grow by 50.18% on average per year.
Based on estimates for the next years, NCNO will show a quite strong growth in Revenue. The Revenue will grow by 17.35% on average per year.
EPS Next Y55.6%
EPS Next 2Y51.48%
EPS Next 3Y50.18%
EPS Next 5YN/A
Revenue Next Year20.08%
Revenue Next 2Y14.78%
Revenue Next 3Y17.35%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 58.86, the valuation of NCNO can be described as expensive.
Based on the Price/Earnings ratio, NCNO is valued a bit cheaper than 62.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of NCNO to the average of the S&P500 Index (24.55), we can say NCNO is valued expensively.
The Price/Forward Earnings ratio is 54.75, which means the current valuation is very expensive for NCNO.
NCNO's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of NCNO to the average of the S&P500 Index (20.92), we can say NCNO is valued expensively.
Industry RankSector Rank
PE 58.86
Fwd PE 54.75

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NCNO.
NCNO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 64.19
EV/EBITDA 308.78

4.3 Compensation for Growth

NCNO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NCNO's earnings are expected to grow with 50.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y51.48%
EPS Next 3Y50.18%

0

5. Dividend

5.1 Amount

No dividends for NCNO!.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (5/1/2024, 7:12:20 PM)

After market: 30.5 +0.48 (+1.6%)

30.02

+0.86 (+2.95%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.43B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 58.86
Fwd PE 54.75
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.16%
ROE -4.03%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 59.86%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)355%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y55.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.71%
Revenue growth 3Y32.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y